Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alves

Showing results (581-590 of 604) with videos related to

Pageof 61
Sort By:
Iscience|November 1, 2021
Polyclonal F(ab')<sub>2</sub> fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potencyLuis Eduardo R Cunha, Adilson A Stolet, Marcelo A Strauch, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 15, 2017
Adverse birth outcomes associated with Zika virus exposure during pregnancy in São José do Rio Preto, BrazilM L Nogueira, N R R Nery Júnior, C F Estofolete, et al.
Physical Review Letters|January 30, 2018
Enhanced Control and Reproducibility of Non-Neutral PlasmasM Ahmadi, B X R Alves, C J Baker, et al.
Nature|April 6, 2018
Characterization of the 1S-2S transition in antihydrogenM Ahmadi, B X R Alves, C J Baker, et al.
Nature|December 21, 2017
Erratum: Observation of the hyperfine spectrum of antihydrogenM Ahmadi, B X R Alves, C J Baker, et al.
Nature Communications|September 27, 2017
Antihydrogen accumulation for fundamental symmetry testsM Ahmadi, B X R Alves, C J Baker, et al.
Nature|August 24, 2018
Observation of the 1S-2P Lyman-α transition in antihydrogenM Ahmadi, B X R Alves, C J Baker, et al.
Nature|August 4, 2017
Observation of the hyperfine spectrum of antihydrogenM Ahmadi, B X R Alves, C J Baker, et al.
Nature|December 23, 2016
Observation of the 1S-2S transition in trapped antihydrogenM Ahmadi, B X R Alves, C J Baker, et al.
Human Vaccines & Immunotherapeutics|September 12, 2015
Booster dose after 10 years is recommended following 17DD-YF primary vaccinationAna Carolina Campi-Azevedo, Christiane Costa-Pereira, Lis R Antonelli, et al.
Pageof 61

Showing results (581-590 of 604) with videos related to

Sort By:
Pageof 61
Iscience|November 1, 2021
Polyclonal F(ab')<sub>2</sub> fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potencyLuis Eduardo R Cunha, Adilson A Stolet, Marcelo A Strauch, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 15, 2017
Adverse birth outcomes associated with Zika virus exposure during pregnancy in São José do Rio Preto, BrazilM L Nogueira, N R R Nery Júnior, C F Estofolete, et al.
Physical Review Letters|January 30, 2018
Enhanced Control and Reproducibility of Non-Neutral PlasmasM Ahmadi, B X R Alves, C J Baker, et al.
Nature|April 6, 2018
Characterization of the 1S-2S transition in antihydrogenM Ahmadi, B X R Alves, C J Baker, et al.
Nature|December 21, 2017
Erratum: Observation of the hyperfine spectrum of antihydrogenM Ahmadi, B X R Alves, C J Baker, et al.
Nature Communications|September 27, 2017
Antihydrogen accumulation for fundamental symmetry testsM Ahmadi, B X R Alves, C J Baker, et al.
Nature|August 24, 2018
Observation of the 1S-2P Lyman-α transition in antihydrogenM Ahmadi, B X R Alves, C J Baker, et al.
Nature|August 4, 2017
Observation of the hyperfine spectrum of antihydrogenM Ahmadi, B X R Alves, C J Baker, et al.
Nature|December 23, 2016
Observation of the 1S-2S transition in trapped antihydrogenM Ahmadi, B X R Alves, C J Baker, et al.
Human Vaccines & Immunotherapeutics|September 12, 2015
Booster dose after 10 years is recommended following 17DD-YF primary vaccinationAna Carolina Campi-Azevedo, Christiane Costa-Pereira, Lis R Antonelli, et al.
Pageof 61